Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ITMR

Itamar Medical (ITMR) Stock Price, News & Analysis

Itamar Medical logo

About Itamar Medical Stock (NASDAQ:ITMR)

Advanced Chart

Key Stats

Today's Range
$30.87
$30.87
50-Day Range
$30.54
$30.87
52-Week Range
$16.36
$30.91
Volume
N/A
Average Volume
90,796 shs
Market Capitalization
$497.25 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Itamar Medical Ltd. engages in the research, development, marketing, selling, and leasing of non-invasive medical devices based on peripheral arterial tone signals. It develops and markets two products, namely, WatchPAT and EndoPAT. The WatchPAT diagnoses sleep apnea, which has been proven to be a substantial risk factor in cardiac disease. The EndoPAT diagnoses endothelial malfunction, which is a proven predictor of cardiovascular disease. The company was founded by Yaron Giora , Martin Gerstel, Peretz Lavie, and Daniel Gur on January 15, 1997 and is headquartered in Caesarea, Israel.

Receive ITMR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Itamar Medical and its competitors with MarketBeat's FREE daily newsletter.

ITMR Stock News Headlines

ITMR Historical Data
Trump to redistribute trillions of dollars
Seeing how the media and other analysts are covering Trump’s actions – it’s laughable. At least it would be laughable if it wasn’t putting so many Americans’ financial futures at severe risk… That’s why, with the 100-day mark of Trump’s second term just days away, it’s time to shine a light on what’s really going on, because if you move your money out of the wrong places and into the right ones before it’s too late… …you could be one of the few who profits from this imminent trillion-dollar reset.
Read Your Way Around the World
Find the Best Medical Schools
Sarit Packer and Itamar Srulovich
ZOLL Announces Closing of Acquisition of Itamar Medical
See More Headlines

ITMR Stock Analysis - Frequently Asked Questions

Itamar Medical Ltd. (NASDAQ:ITMR) issued its quarterly earnings results on Thursday, November, 18th. The company reported ($0.49) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.17) by $0.32. The company earned $13.57 million during the quarter, compared to analyst estimates of $13.70 million.

Itamar Medical subsidiaries include I.M.E. 2016 B.V., Itamar Medical Inc., and Itamar Medical Japan Co. Ltd..

Based on aggregate information from My MarketBeat watchlists, some other companies that Itamar Medical investors own include AbbVie (ABBV), Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM), Gilead Sciences (GILD), Cheniere Energy (LNG), M&T Bank (MTB) and Energy Transfer (ET).

Company Calendar

Last Earnings
11/18/2021
Today
5/08/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:ITMR
Fax
N/A
Employees
257
Year Founded
1997

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$41.03 million
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$497.25 million
Optionable
Not Optionable
Beta
0.73

Social Links

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:ITMR) was last updated on 5/8/2025 by MarketBeat.com Staff
From Our Partners